MedChemExpress Revenue and Competitors
Estimated Revenue & Valuation
- MedChemExpress's estimated annual revenue is currently $75M per year.
- MedChemExpress's estimated revenue per employee is $765,306
Employee Data
- MedChemExpress has 98 Employees.
- MedChemExpress grew their employee count by 23% last year.
MedChemExpress's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Technology, Operation and Support | Reveal Email/Phone |
2 | Regional Sales Director New England | Reveal Email/Phone |
3 | Sales Manager | Reveal Email/Phone |
4 | President | Reveal Email/Phone |
5 | Technical Sales Specialist (AU & NZ) | Reveal Email/Phone |
6 | Product and Service Specialist | Reveal Email/Phone |
7 | Technical Sales Representative | Reveal Email/Phone |
MedChemExpress Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 17 | -6% | N/A | N/A |
#2 | $35M | 133 | -13% | N/A | N/A |
#3 | N/A | 4859 | 0% | N/A | N/A |
#4 | $35M | 300 | N/A | N/A | N/A |
#5 | $750M | 1540 | 25% | N/A | N/A |
#6 | $35M | 310 | 1% | N/A | N/A |
#7 | $300M | 218 | 10% | N/A | N/A |
#8 | $7.5M | 63 | 3% | N/A | N/A |
#9 | $75M | 992 | 17% | N/A | N/A |
#10 | N/A | 7 | 0% | N/A | N/A |
What Is MedChemExpress?
MedChemExpress has an experienced team of synthesis chemists. Led by excellent scientists, our chemical synthesis team is capable of supporting all kinds of chemistry projects, even multiple step synthesis of complex molecules, such as metabolites and steroids. MedChemExpress has always been committed to develop the most optimized synthetic route and high-quality products that exceed international standards. With rich experiences in preparing a large number of different bioactive molecules, we can provide your customized compounds more rapidly than other companies. Our company is dedicated to providing customers with all kinds of high quality bioactive small molecules, including inhibitors, antagonists, agonists and modulators. We own a comprehensive product line and offer professional after-sale services to achieve customer satisfaction. Our products have been widely used in various fields of biopharmaceutical research and development, especially in the research focus areas such as cancer, infection, autoimmune diseases, diabetes, cardiovascular diseases and neurodegenerative diseases. Our tech-support team classifies products into Apoptosis, Epigenetics, Wnt/Hedgehog/Notch, PI3K/Akt/mTOR, etc., according to the basic biological theory of signaling pathways which cover all aspects of the pathogenesis of diseases.
keywords:N/AN/A
Total Funding
98
Number of Employees
$75M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35M | 115 | 6% | N/A |
#2 | $19.7M | 136 | -1% | N/A |
#3 | $11.9M | 143 | 29% | N/A |
#4 | $46.9M | 170 | 4% | N/A |
#5 | $53.2M | 182 | 1% | $22.6M |